Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function
about
Neuro-modulating effects of honokiol: a reviewHonokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma modelChronic over-nutrition and dysregulation of GSK3 in diseasesHonokiol: a novel natural agent for cancer prevention and therapyMultiple effects of Honokiol on the life cycle of hepatitis C virusElimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme CellsImmunocompetent murine models for the study of glioblastoma immunotherapyHonokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds.Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells.Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination.Honokiol induces cell cycle arrest and apoptosis via p53 activation in H4 human neuroglioma cellsPI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasionImplications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.Immune-checkpoint blockade and active immunotherapy for glioma.CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.Honokiol inhibits androgen receptor activity in prostate cancer cellsBlocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy.Therapeutic targeting of B7-H1 in breast cancer.PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.Certain Diet and Lifestyle May Contribute to Islet β-cells Protection in Type-2 Diabetes via the Modulation of Cellular PI3K/AKT Pathway.Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.Honokiol inhibits hypoxia-inducible factor-1 pathway.Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.Highlights from the latest articles in glioma immunotherapy.
P2860
Q21129428-31D843A1-44C1-4F35-8C59-740249CB763EQ21560841-099F0C02-F7D3-4DAD-8476-1D94F55797BCQ26738964-97E30706-3043-4AD4-A1BD-892CF7CA008BQ27027050-6350502B-DEA9-4E32-8629-E58561081B0DQ28253400-F1CD3BA9-68A3-4957-B71E-4F312DF04BE2Q30048454-914073DF-F4D2-476D-A8DF-6CBC43427B99Q33574853-C1A85180-052B-4227-95D1-A662BB1D77D7Q33919087-AF443C66-BCC3-4976-AD33-B43FF78493BFQ34143126-E722F1C4-442E-4023-8E3F-1D01F80A300BQ34891746-13ECAAFF-81CF-4199-BBE5-230422FB2997Q35159355-5629DE87-8205-4CE4-9619-3CA02BE2E293Q35623465-6959F55E-825F-44D1-98B2-0B65A44F5931Q35722027-36F30755-B0B0-452B-B8D8-5D58D0C37C31Q36086507-8C0A04D6-1682-4AE8-92F4-975DA85C2837Q36883024-AD16C765-78E3-4294-89DA-FCADFB4E66C4Q37226831-1F4CBF09-BC8A-4D70-895A-52590E1305A4Q37301756-D256E189-1CE0-4A0C-9DE5-3768241F11B5Q37420586-82F04F01-42BE-464B-8DAC-7DC79A75875FQ37422094-E207D57A-920C-4F3B-BC18-C5AF641C0397Q37625379-E0739F41-1AA4-41C0-806B-78076AE47268Q37741143-25772C8C-67B0-4121-B434-A112A77D3CF4Q37922793-DCE6B6D7-5B0F-4CC1-B8B5-6BFD7C740306Q37951937-1891FEA8-C3F4-4BDA-A2F5-F843DBB73201Q38104756-8555F231-EB69-4985-82F5-91958FF5F66AQ38261369-D3E4E620-FC43-4886-AE97-32B7B3FA0443Q38268646-46713EB0-FAEB-4967-B688-AD65A3B629CBQ39593159-A984436C-B98F-4954-8A93-FFE67E4884D1Q45903004-68EAB05D-B4BF-4638-BD5A-AA85464BCD3FQ48428544-AB6AE6C5-4F6A-49E2-BCC6-55829654E082Q49379995-8EAB7209-4BAF-4C6A-A808-06FBC287963BQ55463970-900493A2-F773-4CBD-9BAA-0073D8FBBE32
P2860
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Honokiol-mediated inhibition o ...... hout impacting T cell function
@ast
Honokiol-mediated inhibition o ...... hout impacting T cell function
@en
Honokiol-mediated inhibition o ...... hout impacting T cell function
@nl
type
label
Honokiol-mediated inhibition o ...... hout impacting T cell function
@ast
Honokiol-mediated inhibition o ...... hout impacting T cell function
@en
Honokiol-mediated inhibition o ...... hout impacting T cell function
@nl
prefLabel
Honokiol-mediated inhibition o ...... hout impacting T cell function
@ast
Honokiol-mediated inhibition o ...... hout impacting T cell function
@en
Honokiol-mediated inhibition o ...... hout impacting T cell function
@nl
P2093
P2860
P3181
P1476
Honokiol-mediated inhibition o ...... hout impacting T cell function
@en
P2093
Amith Panner
Andrew T Parsa
Courtney Crane
Jack Arbiser
Russell O Pieper
P2860
P304
P3181
P356
10.1097/CJI.0B013E3181A8EFE6
P407
P50
P577
2009-01-01T00:00:00Z